Jessie L.‐S. Au

11.6k total citations · 1 hit paper
164 papers, 7.1k citations indexed

About

Jessie L.‐S. Au is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Jessie L.‐S. Au has authored 164 papers receiving a total of 7.1k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Molecular Biology, 54 papers in Oncology and 30 papers in Surgery. Recurrent topics in Jessie L.‐S. Au's work include Nanoparticle-Based Drug Delivery (25 papers), Cancer Treatment and Pharmacology (22 papers) and RNA Interference and Gene Delivery (20 papers). Jessie L.‐S. Au is often cited by papers focused on Nanoparticle-Based Drug Delivery (25 papers), Cancer Treatment and Pharmacology (22 papers) and RNA Interference and Gene Delivery (20 papers). Jessie L.‐S. Au collaborates with scholars based in United States, Taiwan and Australia. Jessie L.‐S. Au's co-authors include M. Guillaume Wientjes, Ze Lu, Seong H. Jang, Jie Wang, Dan Lü, Yuebo Gan, Liang Zhao, Robert A. Badalament, M. Guill Wientjes and Di Song and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.

In The Last Decade

Jessie L.‐S. Au

162 papers receiving 6.9k citations

Hit Papers

Delivery of siRNA Therapeutics: Barriers and Carriers 2010 2026 2015 2020 2010 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jessie L.‐S. Au United States 44 3.0k 1.6k 1.6k 1.3k 1.2k 164 7.1k
M. Guillaume Wientjes United States 42 2.6k 0.9× 1.3k 0.8× 1.5k 0.9× 1.3k 1.0× 1.2k 1.0× 129 6.2k
Peter Müller Germany 48 4.2k 1.4× 688 0.4× 818 0.5× 1.4k 1.1× 559 0.5× 286 8.7k
Walter Sebald Germany 62 6.6k 2.2× 1.1k 0.7× 423 0.3× 854 0.7× 1.3k 1.1× 201 10.8k
Herman Yeger Canada 56 7.6k 2.5× 2.8k 1.7× 690 0.4× 2.0k 1.6× 526 0.4× 213 13.1k
Vyomesh Patel United States 50 5.7k 1.9× 1.9k 1.2× 494 0.3× 491 0.4× 2.2k 1.8× 111 9.1k
Jer‐Tsong Hsieh United States 63 7.5k 2.5× 3.4k 2.1× 746 0.5× 1.0k 0.8× 1.1k 0.9× 267 12.9k
Xiangwei Wu China 42 5.6k 1.9× 2.5k 1.5× 262 0.2× 713 0.6× 541 0.4× 142 9.1k
Gregg B. Fields United States 52 3.7k 1.2× 2.3k 1.4× 1.3k 0.8× 343 0.3× 480 0.4× 157 7.8k
Bruce R. Zetter United States 61 7.9k 2.6× 2.5k 1.5× 609 0.4× 1.1k 0.9× 887 0.7× 154 13.5k
Dawei Xu Sweden 53 4.3k 1.4× 1.3k 0.8× 521 0.3× 649 0.5× 632 0.5× 207 8.7k

Countries citing papers authored by Jessie L.‐S. Au

Since Specialization
Citations

This map shows the geographic impact of Jessie L.‐S. Au's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jessie L.‐S. Au with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jessie L.‐S. Au more than expected).

Fields of papers citing papers by Jessie L.‐S. Au

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jessie L.‐S. Au. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jessie L.‐S. Au. The network helps show where Jessie L.‐S. Au may publish in the future.

Co-authorship network of co-authors of Jessie L.‐S. Au

This figure shows the co-authorship network connecting the top 25 collaborators of Jessie L.‐S. Au. A scholar is included among the top collaborators of Jessie L.‐S. Au based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jessie L.‐S. Au. Jessie L.‐S. Au is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Yajing, Ze Lu, John A. Taylor, & Jessie L.‐S. Au. (2023). Quantitative image analysis of intracellular protein translocation in 3-dimensional tissues for pharmacodynamic studies of immunogenic cell death. Journal of Controlled Release. 365. 89–100.
2.
Abbiati, R., M. Guillaume Wientjes, & Jessie L.‐S. Au. (2021). Is It Time to Use Modeling of Cellular Transporter Homeostasis to Inform Drug-Drug Interaction Studies: Theoretical Considerations. The AAPS Journal. 23(5). 102–102. 1 indexed citations
3.
Gan, Yuebo, Jie Lu, Bertrand Z. Yeung, et al.. (2014). Pharmacodynamics of Telomerase Inhibition and Telomere Shortening by Noncytotoxic Suramin. The AAPS Journal. 17(1). 268–276. 14 indexed citations
4.
Tsai, Max, Ze Lu, M. Guillaume Wientjes, & Jessie L.‐S. Au. (2013). Paclitaxel-loaded polymeric microparticles: Quantitative relationships between in vitro drug release rate and in vivo pharmacodynamics. Journal of Controlled Release. 172(3). 737–744. 33 indexed citations
5.
Álvarez, Francisco J., William C. Kisseberth, Kenji Hosoya, et al.. (2013). Postoperative Adjuvant Combination Therapy with Doxorubicin and Noncytotoxic Suramin in Dogs with Appendicular Osteosarcoma. Journal of the American Animal Hospital Association. 50(1). 12–18. 10 indexed citations
6.
Li, Yinghuan, Jie Wang, M. Guillaume Wientjes, & Jessie L.‐S. Au. (2011). Delivery of nanomedicines to extracellular and intracellular compartments of a solid tumor. Advanced Drug Delivery Reviews. 64(1). 29–39. 180 indexed citations
7.
Shen, Zancong, Tong Shen, M. Guillaume Wientjes, Michael A. O’Donnell, & Jessie L.‐S. Au. (2008). Intravesical Treatments of Bladder Cancer: Review. Pharmaceutical Research. 25(7). 1500–1510. 135 indexed citations
8.
Au, Jessie L.‐S., Thomas Olencki, M. Guillaume Wientjes, et al.. (2007). P2-230: A Phase I Study of Nontoxic Suramin As A Chemosensitizer In Pretreated/Refractory Non-Small Cell Lung Cancer (NSCLC) Patients. Journal of Thoracic Oncology. 2(8). S663–S664. 1 indexed citations
9.
Yu, Bei, Yong Wei, SaeHeum Song, M. Guillaume Wientjes, & Jessie L.‐S. Au. (2006). bFGF as a therapeutic target for chemosensitization in colorectal cancer.. Cancer Research. 66. 1295–1296. 1 indexed citations
10.
Kosarek, Carrie E., Xiao Hu, C. Guillermo Couto, et al.. (2006). Phase I Evaluation of Low-Dose Suramin as Chemosensitizer of Doxorubicin in Dogs with Naturally Occurring Cancers. Journal of Veterinary Internal Medicine. 20(5). 1172–1177. 4 indexed citations
11.
Gan, Yuebo, M. Guillaume Wientjes, & Jessie L.‐S. Au. (2006). Expression of Basic Fibroblast Growth Factor Correlates with Resistance to Paclitaxel in Human Patient Tumors. Pharmaceutical Research. 23(6). 1324–1331. 59 indexed citations
12.
Yan, Xin, et al.. (2004). Low-dose suramin enhances antitumor activity of mitomycin C in bladder tumors. Cancer Research. 64. 461–461. 3 indexed citations
13.
Au, Jessie L.‐S., Seong H. Jang, & M. Guill Wientjes. (2002). Clinical aspects of drug delivery to tumors. Journal of Controlled Release. 78(1-3). 81–95. 66 indexed citations
14.
Song, SaeHeum, M. Guillaume Wientjes, Yuebo Gan, & Jessie L.‐S. Au. (2000). Fibroblast growth factors: An epigenetic mechanism of broad spectrum resistance to anticancer drugs. Proceedings of the National Academy of Sciences. 97(15). 8658–8663. 164 indexed citations
15.
Gan, Yuebo, Jessie L.‐S. Au, Jie Lu, & M. Guillaume Wientjes. (1998). Antiproliferative and Cytotoxic Effects of Geldanamycin, Cytochalasin E, Suramin and Thiacetazone in Human Prostate Xenograft Tumor Histocultures. Pharmaceutical Research. 15(11). 1760–1766. 22 indexed citations
16.
Au, Jessie L.‐S., Xiaoxu Gao, Yu Gan, et al.. (1997). Time-dependent taxol cytotoxicity. 38. 4. 1 indexed citations
17.
Au, Jessie L.‐S., et al.. (1997). Application of automatic thresholding in image analysis scoring of cells in human solid tumors labeled for proliferation markers. Cytometry. 29(2). 128–135. 19 indexed citations
18.
Song, Di, et al.. (1996). Binding of Taxol to Plastic and Glass Containers and Protein under in Vitro Conditions. Journal of Pharmaceutical Sciences. 85(1). 29–31. 66 indexed citations
19.
Wientjes, M. Guillaume, et al.. (1992). Nonlinear Disposition of Intravenous 2′,3′-Dideoxyinosine in Rats. Pharmaceutical Research. 9(8). 1070–1075. 16 indexed citations
20.
Au, Jessie L.‐S., et al.. (1978). Hydroxylated metabolies of R,S-1-(tetrahydro-2-furanyl)-5-fluorouracil (Ftorafur) in rats and rabbits.. PubMed. 38(1). 210–4. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026